Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1185

  • The following term was ignored: -
  • See the search details.
1.

The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.

Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD.

Eur J Heart Fail. 2018 Feb 21. doi: 10.1002/ejhf.1159. [Epub ahead of print] Review.

PMID:
29464817
2.

Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.

Lévy BI, Taddei S.

Curr Med Res Opin. 2018 Feb 19:1-14. doi: 10.1080/03007995.2018.1425674. [Epub ahead of print]

PMID:
29307229
3.

[Ambulatory cardiac rehabilitation in Trieste: protocols of intervention, activities and outcomes].

Doimo S, Maras P, Barbati G, Fabris E, Della Mattia A, Salame K, Gatti G, Sinagra G.

G Ital Cardiol (Rome). 2017 Dec;18(12):862-870. doi: 10.1714/2815.28470. Italian.

PMID:
29189830
4.

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.

Shen L, Ramires F, Martinez F, Bodanese LC, Echeverría LE, Gómez EA, Abraham WT, Dickstein K, Køber L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees.

Circ Heart Fail. 2017 Nov;10(11). pii: e004361. doi: 10.1161/CIRCHEARTFAILURE.117.004361.

PMID:
29141857
5.

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.

Volpe M, Tocci G, de la Sierra A, Kreutz R, Laurent S, Manolis AJ, Tsioufis K.

High Blood Press Cardiovasc Prev. 2017 Dec;24(4):463-472. doi: 10.1007/s40292-017-0239-7. Epub 2017 Oct 31.

6.

Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center.

Arakkal G, Chintagunta SR, Chandika V, Damarla SV, Manchala S, Kumar BU.

Indian J Dermatol Venereol Leprol. 2017 Nov-Dec;83(6):677-682. doi: 10.4103/0378-6323.198453.

8.

Update of treatment of heart failure with reduction of left ventricular ejection fraction.

Aronow WS.

Arch Med Sci Atheroscler Dis. 2016 Oct 17;1(1):e106-e116. doi: 10.5114/amsad.2016.63002. eCollection 2016.

9.

Moderately Elevated Blood Pressure: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2004 Oct.

10.

Moderately Elevated Blood Pressure: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Sep.

11.

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.

Brugts JJ, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML, Boersma E.

Cardiovasc Drugs Ther. 2017 Aug;31(4):391-400. doi: 10.1007/s10557-017-6747-9.

12.

[New pharmacologic therapies for chronic heart failure].

Kempf T, Bavendiek U, Bauersachs J.

Internist (Berl). 2017 Sep;58(9):990-999. doi: 10.1007/s00108-017-0277-1. Review. German.

PMID:
28653148
13.

Renin Inhibition with Aliskiren: A Decade of Clinical Experience.

Pantzaris ND, Karanikolas E, Tsiotsios K, Velissaris D.

J Clin Med. 2017 Jun 9;6(6). pii: E61. doi: 10.3390/jcm6060061. Review.

14.

RAS Genetic Variants in Interaction with ACE Inhibitors Drugs Influences Essential Hypertension Control.

Heidari F, Vasudevan R, Mohd Ali SZ, Ismail P, Arkani M.

Arch Med Res. 2017 Jan;48(1):88-95. doi: 10.1016/j.arcmed.2017.03.003.

PMID:
28577874
15.

Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine.

Nguyen P, Kamran H, Nasir S, Chan W, Shah T, Deswal A, Bozkurt B.

Am J Cardiol. 2017 Jun 15;119(12):2030-2034. doi: 10.1016/j.amjcard.2017.03.034. Epub 2017 Mar 29.

PMID:
28456314
16.

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.

Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Kostaki S, Papadopoulou M, Angelopoulou SM, Margariti E, Savopoulos C, Hatzitolios AI.

Clin Exp Hypertens. 2017;39(3):246-250. doi: 10.1080/10641963.2016.1246561.

PMID:
28448189
17.

Management of Essential Hypertension.

Ferdinand KC, Nasser SA.

Cardiol Clin. 2017 May;35(2):231-246. doi: 10.1016/j.ccl.2016.12.005. Review.

PMID:
28411897
18.

Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.

Regoli D, Gobeil F.

Can J Physiol Pharmacol. 2017 Oct;95(10):1117-1124. doi: 10.1139/cjpp-2016-0619. Epub 2017 Apr 6. Review.

PMID:
28384411
19.

Blood pressure lowering efficacy of renin inhibitors for primary hypertension.

Musini VM, Lawrence KA, Fortin PM, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2017 Apr 5;4:CD007066. doi: 10.1002/14651858.CD007066.pub3. Review.

PMID:
28379619
20.

Management of hypertension in 2017: targets and therapies.

Ahluwalia M, Bangalore S.

Curr Opin Cardiol. 2017 Jul;32(4):413-421. doi: 10.1097/HCO.0000000000000408.

PMID:
28346238

Supplemental Content

Loading ...
Support Center